Maca Plus
Maca Plus, licence 80077591: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Prohealth Centre Inc.
- NPN or DIN-HM
- 80077591
- Status
- Active licence
- Licence date
- 18 May 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Tribulus terrestris L.: Les parties de plantes doivent être cuites
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Epimedium brevicornu Source : Feuille Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1.5 Grammes | 150.0 milligramme | Not calculated |
| Cynomorium songaricum Source : Tige Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 400 milligramme | 40.0 milligramme | Not calculated |
| Panax ginseng Source : Racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 675 milligramme | 135.0 milligramme | Not calculated |
| Lycium barbarum Source : Fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 300 milligramme | 30.0 milligramme | Not calculated |
| Lepidium meyenii Source : Racine et stolon Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 750 milligramme | 75.0 milligramme | Not calculated |
| Tribulus terrestris Source : Fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 0.6 Grammes | 60.0 milligramme | Not calculated |
Non-medicinal ingredients
Safran, Hypromellose, Cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
(Used in Herbal Medicine as) supportive therapy for the promotion of healthy glucose levels. (Used in Herbal Medicine to) help(s) support cognitive function and/or reduce mental fatigue (in cases of mental stress). Used in Herbal Medicine to help enhance physical capacity/performance (in cases of physical stress). Source of antioxidant(s)/Provides antioxidant(s). Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Some people may experience insomnia, anxiety, or headaches, in which case, discontinue use. If dizziness, vomiting, dry mouth, thirst or nosebleed occur, discontinue use. Hypersensitivity/allergy has been known to occur; in which case, discontinue use.
- Précautions et mises en garde
If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. If you are taking prescription medications, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are taking antidepressant medications. Consult a health care practitioner prior to use if you are taking blood thinners or digoxin. Consult a health care practitioner prior to use if you have diabetes. If you are taking antidepressants, consult a health care practitioner prior to use. If you are taking blood thinners, consult a health care practitioner prior to use. If you have high blood pressure, consult a health care practitioner prior to use. If you suffer from any psychological disorder and/or condition such as frequent anxiety or depression, consult a healthcare practitioner prior to use. Consult a health care practitioner prior to use if you suffer from a hormone-sensitive condition.
- Contre-indications
If you are pregnant or breastfeeding, do not use this product.
Source
Official Health Canada record, licence 80077591
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.